Sabadell Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.78M | Sell |
14,642
-1,029
| -7% | -$195K | 0.58% | 50 |
|
|
2023
Q1 | $3.15M | Sell |
15,671
-534
| -3% | -$107K | 0.67% | 50 |
|
|
2022
Q4 | $3.65M | Sell |
16,205
-22,977
| -59% | -$5.17M | 0.76% | 53 |
|
|
2022
Q3 | $7.88M | Buy |
39,182
+4,650
| +13% | +$935K | 1.73% | 19 |
|
|
2022
Q2 | $4.78M | Hold |
34,532
| – | – | 1.01% | 30 |
|
|
2022
Q1 | $5.6M | Buy |
+34,532
| New | +$5.6M | 0.97% | 29 |
|